Back to Search
Start Over
Pegaptanib shows promise as adjunct to PDR treatment.
- Source :
-
Ophthalmology Times . 8/1/2008, Vol. 33 Issue 15, p18-18. 2/3p. - Publication Year :
- 2008
-
Abstract
- The article focuses on the study of the significance and usefulness of pegaptanib sodium in treating proliferative diabetic retinopathy (DPR) in Fort Lauderdale, Florida. The clinical findings of the therapeutic drug is presented at the annual meeting of the Association for Research in Vision and Ophthalmology. Pegaptanib is recognized as one of the first anti-vascular endothelial growth factor (VEGF) inhibitors approved for PDR treatment.
Details
- Language :
- English
- ISSN :
- 0193032X
- Volume :
- 33
- Issue :
- 15
- Database :
- Academic Search Index
- Journal :
- Ophthalmology Times
- Publication Type :
- Periodical
- Accession number :
- 34001378